Literature DB >> 33777321

Fucoxanthin Prevents 6-OHDA-Induced Neurotoxicity by Targeting Keap1.

Wei Wu1, Hui Han1, Jingwangwei Liu1, Min Tang1, Xiaoyu Wu1, Xiaojun Cao1, Tiantian Zhao1, Yujia Lu1, Tingting Niu1, Juanjuan Chen1, Haimin Chen1.   

Abstract

As the most abundant marine carotenoid extracted from seaweeds, fucoxanthin (FUC) is considered to have excellent neuroprotective activity. However, the target of FUC for its neuroprotective properties remains largely unclear. Oxidative stress is one of the initiating factors causing neuronal cell loss and necrosis, and it is also an important inducement of Parkinson's disease (PD). In the present study, the neuroprotective effect of FUC was assessed using a 6-hydroxydopamine- (6-OHDA-) induced neurotoxicity model. FUC suppressed 6-OHDA-induced accumulation of intracellular ROS, the disruption of mitochondrial membrane potential, and cell apoptosis through the Nrf2-ARE pathway. Keap1 as a repressor of Nrf2 can regulate the activity of Nrf2. Here, the biolayer interferometry (BLI) assay demonstrated that FUC specifically targeted Keap1 and inhibited the interaction between Keap1 and Nrf2. FUC bound to the hydrophobic region of Keap1 pocket and formed hydrogen bonding interactions with Arg415 and Tyr525. Besides, it also dose-dependently upregulated the expressions of antioxidant enzymes, such as nicotinamide heme oxygenase-1, glutamate-cysteine ligase modifier subunit, and glutamate-cysteine ligase catalytic subunit, in 6-OHDA-induced PC12 cells. In 6-OHDA-exposed zebrafish, FUC pretreatment significantly increased the total swimming distance of zebrafish larvae and improved the granular region of the brain tissue damage. These results suggested that FUC could protect the neuronal cells against 6-OHDA-induced injury via targeting Keap1.
Copyright © 2021 Wei Wu et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33777321      PMCID: PMC7972864          DOI: 10.1155/2021/6688708

Source DB:  PubMed          Journal:  Oxid Med Cell Longev        ISSN: 1942-0994            Impact factor:   6.543


  49 in total

1.  p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly.

Authors:  Yasuhiko Izumi; Hideyuki Sawada; Noriko Sakka; Noriyuki Yamamoto; Toshiaki Kume; Hiroshi Katsuki; Shun Shimohama; Akinori Akaike
Journal:  J Neurosci Res       Date:  2005-03-15       Impact factor: 4.164

2.  Nrf2 amplifies oxidative stress via induction of Klf9.

Authors:  Shoshanna N Zucker; Emily E Fink; Archis Bagati; Sudha Mannava; Anna Bianchi-Smiraglia; Paul N Bogner; Joseph A Wawrzyniak; Colleen Foley; Katerina I Leonova; Melissa J Grimm; Kalyana Moparthy; Yurij Ionov; Jianmin Wang; Song Liu; Sandra Sexton; Eugene S Kandel; Andrei V Bakin; Yuesheng Zhang; Naftali Kaminski; Brahm H Segal; Mikhail A Nikiforov
Journal:  Mol Cell       Date:  2014-03-06       Impact factor: 17.970

3.  Neuroprotective effects of pyrroloquinoline quinone against rotenone injury in primary cultured midbrain neurons and in a rat model of Parkinson's disease.

Authors:  Qi Zhang; Shuhua Chen; Shu Yu; Jiaojiao Qin; Jingjing Zhang; Qiong Cheng; Kaifu Ke; Fei Ding
Journal:  Neuropharmacology       Date:  2016-04-20       Impact factor: 5.250

4.  The delayed effects of antibiotics in type 2 diabetes, friend or foe?

Authors:  Lihong Fu; Yixuan Qiu; Linyan Shen; Canqi Cui; Shuang Wang; Shujie Wang; Yun Xie; Xinjie Zhao; Xianfu Gao; Guang Ning; Aifang Nie; Yanyun Gu
Journal:  J Endocrinol       Date:  2018-06-21       Impact factor: 4.286

5.  Gallic Acid Protects 6-OHDA Induced Neurotoxicity by Attenuating Oxidative Stress in Human Dopaminergic Cell Line.

Authors:  Y Chandrasekhar; G Phani Kumar; E M Ramya; K R Anilakumar
Journal:  Neurochem Res       Date:  2018-04-18       Impact factor: 3.996

6.  Studies on the bioactivities and molecular mechanism of antioxidant peptides by 3D-QSAR, in vitro evaluation and molecular dynamic simulations.

Authors:  Wenli Yan; Guimei Lin; Rong Zhang; Zhen Liang; Wenjuan Wu
Journal:  Food Funct       Date:  2020-04-30       Impact factor: 5.396

7.  Regulation of Keap1-Nrf2 signaling: The role of epigenetics.

Authors:  David Cheng; Renyi Wu; Yue Guo; Ah-Ng Tony Kong
Journal:  Curr Opin Toxicol       Date:  2016-11-05

Review 8.  Glutathione metabolism and Parkinson's disease.

Authors:  Michelle Smeyne; Richard Jay Smeyne
Journal:  Free Radic Biol Med       Date:  2013-05-08       Impact factor: 7.376

9.  Fucoxanthin, a Marine Carotenoid, Attenuates β-Amyloid Oligomer-Induced Neurotoxicity Possibly via Regulating the PI3K/Akt and the ERK Pathways in SH-SY5Y Cells.

Authors:  Jiajia Lin; Jie Yu; Jiaying Zhao; Ke Zhang; Jiachen Zheng; Jialing Wang; Chunhui Huang; Jingrong Zhang; Xiaojun Yan; William H Gerwick; Qinwen Wang; Wei Cui; Shan He
Journal:  Oxid Med Cell Longev       Date:  2017-08-08       Impact factor: 6.543

10.  Investigation of Molecular Details of Keap1-Nrf2 Inhibitors Using Molecular Dynamics and Umbrella Sampling Techniques.

Authors:  Ashwini Machhindra Londhe; Changdev Gorakshnath Gadhe; Sang Min Lim; Ae Nim Pae
Journal:  Molecules       Date:  2019-11-12       Impact factor: 4.411

View more
  7 in total

Review 1.  A Systematic Review on Marine Algae-Derived Fucoxanthin: An Update of Pharmacological Insights.

Authors:  Md Mohibbullah; Md Nazmul Haque; Abdullah Al Mamun Sohag; Md Tahmeed Hossain; Md Sarwar Zahan; Md Jamal Uddin; Md Abdul Hannan; Il Soo Moon; Jae-Suk Choi
Journal:  Mar Drugs       Date:  2022-04-22       Impact factor: 6.085

Review 2.  Carotenoids from Marine Sources as a New Approach in Neuroplasticity Enhancement.

Authors:  Sylwia Pietrasik; Natalia Cichon; Michal Bijak; Leslaw Gorniak; Joanna Saluk-Bijak
Journal:  Int J Mol Sci       Date:  2022-02-11       Impact factor: 5.923

Review 3.  Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation.

Authors:  Anushruti Ashok; Syed Suhail Andrabi; Saffar Mansoor; Youzhi Kuang; Brian K Kwon; Vinod Labhasetwar
Journal:  Antioxidants (Basel)       Date:  2022-02-17

4.  Fucoxanthin Attenuates Oxidative Damage by Activating the Sirt1/Nrf2/HO-1 Signaling Pathway to Protect the Kidney from Ischemia-Reperfusion Injury.

Authors:  Hu Mao; Lei Wang; Yufeng Xiong; Guanjun Jiang; Xiuheng Liu
Journal:  Oxid Med Cell Longev       Date:  2022-01-28       Impact factor: 6.543

5.  Fucoxanthin Prevents Long-Term Administration l-DOPA-Induced Neurotoxicity through the ERK/JNK-c-Jun System in 6-OHDA-Lesioned Mice and PC12 Cells.

Authors:  Jingwangwei Liu; Yujia Lu; Min Tang; Fanghao Shao; Dongzi Yang; Shuchang Chen; Ziyi Xu; Leilei Zhai; Juanjuan Chen; Qian Li; Wei Wu; Haimin Chen
Journal:  Mar Drugs       Date:  2022-03-31       Impact factor: 6.085

Review 6.  Fucoxanthin from Algae to Human, an Extraordinary Bioresource: Insights and Advances in up and Downstream Processes.

Authors:  Anne Pajot; Gia Hao Huynh; Laurent Picot; Luc Marchal; Elodie Nicolau
Journal:  Mar Drugs       Date:  2022-03-23       Impact factor: 6.085

Review 7.  Advances of Zebrafish in Neurodegenerative Disease: From Models to Drug Discovery.

Authors:  Xiaobo Wang; Jin-Bao Zhang; Kai-Jie He; Fen Wang; Chun-Feng Liu
Journal:  Front Pharmacol       Date:  2021-07-14       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.